eglin proteinase inhibitors (eglin C)
inhibits trypsin, chymotrypsin, leukocyte elastase & cathepsin; see also record for elastase inhibitor, mucus & leukocyte neutral proteinase inhibitors
Also Known As:
eglin C; eglin b; eglins; proteinase inhibitor, eglin c (Hirudo medicinalis)
Networked: 30
relevant articles (3 outcomes,
2 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Beaulieu, Marie-Eve:
1 article
(04/2006)
|
2. | Désilets, Antoine:
1 article
(04/2006)
|
3. | Leduc, Richard:
1 article
(04/2006)
|
4. | Longpré, Jean-Michel:
1 article
(04/2006)
|
5. | Maybauer, Dirk:
1 article
(06/2003)
|
6. | Maybauer, Mark:
1 article
(06/2003)
|
7. | Neuhof, Christiane:
1 article
(06/2003)
|
8. | Neuhof, Heinz:
1 article
(06/2003)
|
9. | Oliva, Maria Luiza V:
1 article
(06/2003)
|
10. | Sampaio, Claudio A M:
1 article
(06/2003)
|
Related Diseases
1. | Emphysema
09/01/1986
- " Eglin-c (2,000 micrograms in 0.5 ml saline) was effective in ameliorating emphysema, as determined histologically and physiologically, when it was given intratracheally to hamsters 1, 2, 4, and 8 h before the intratracheal instillation of 300 micrograms of HNE. " 01/01/1985
- " In an experiment with the hamster emphysema model, 0.5 mg or 2 mg of Eglin c applied intratracheally one hour before an HLE-insult completely protected the animals against emphysema and no signs of toxicity due to Eglin c were observed." 01/01/1986
- " In particular, Eglin c has been proven effective in experimental animal models of emphysema and shock. " 09/01/1990
- " Eglin-c, a compound that inhibits rat elastase but has little effect on porcine pancreatic elastase (PPE), was employed to examine the role of endogenous elastase in PPE-induced emphysema. " 09/01/1990
- " Inhibition of porcine pancreatic elastase-induced emphysema by eglin-c."
|
2. | Shock
|
3. | Coccidiosis
|
4. | Septic Shock (Toxic Shock Syndrome)
|
5. | Pulmonary Edema
|
|
Related Drugs and Biologics
Related Therapies and Procedures